India’s dependency on China for pharma intermediates can change if there is a proper coordination between educational institutes, research institutes and pharma manufacturers
Lenalidomide is used to treat cancer and also some anaemia disorders
The group has a total of 320 ANDA approvals
The acquisition will provide it with a foothold in the US $ 48 billion global animal health market
It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
It strengthens Syngene’s portfolio as a fully integrated custom biomanufacturer with added mammalian and microbial capabilities for clinical and commercial supplies
The company has also applied to DCGI for Emergency Use Authorization (EUA) for ZyCoVD, the world's first Plasmid DNA Vaccine
Nearly 6,000 patients have been treated with the drug since 2017
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
It is part of the company’s pain/analgesics portfolio of OTC products
Subscribe To Our Newsletter & Stay Updated
